biomedcentral.com Biomedcentral.com - Molecular-cancer.biomedcentral.com

   
Molecular *** | Home page

Domain Summary

What is the traffic rank for Molecular-cancer.biomedcentral.com?

• Molecular-cancer.biomedcentral.com ranks #4,107 globally on HypeStat.

What percent of global Internet users visit Molecular-cancer.biomedcentral.com?

• 0.0254% of global Internet users visit Molecular-cancer.biomedcentral.com

How many people visit Molecular-cancer.biomedcentral.com each day?

• Molecular-cancer.biomedcentral.com receives approximately 1.3M visitors and 2,066,132 page impressions per day.

Which countries does Molecular-cancer.biomedcentral.com receive most of its visitors from?

• Molecular-cancer.biomedcentral.com is mostly visited by people located in China,United States,Japan.

How much Molecular-cancer.biomedcentral.com can earn?

• Molecular-cancer.biomedcentral.com should earn about $3,993.09/day from advertising revenue.

What is Molecular-cancer.biomedcentral.com estimated value?

• Estimated value of Molecular-cancer.biomedcentral.com is $3,429,444.93.

What IP addresses does Molecular-cancer.biomedcentral.com resolve to?

• Molecular-cancer.biomedcentral.com resolves to the IP addresses 151.101.196.95.

Where are Molecular-cancer.biomedcentral.com servers located in?

• Molecular-cancer.biomedcentral.com has servers located in Los Angeles, California, 90009, United States.

molecular-cancer.biomedcentral.com Profile

Title:Molecular *** | Home page
Description:An online journal that publishes peer-reviewed research across all areas of biology and medicine with free access, plus commentary, reviews, collaboration tools, and database links.
<p>As an internationally recognized journal, <i>Molecular ***</i> is dedicated to the innovation of how basic *** research drives advances in *** prevention, diagnostics, and treatment. Ranked in the top 25% in the Oncology category of Journal Citation Reports, the journal receives over 70,000 article accesses a month. The journal prides itself on less than 7 days time-to-first-decision, welcoming submissions of broad interest including: target therapies; molecular and cellular biology; genomics; genetics and epigenetics; pathology and tumor immunology. <i>Molecular ***</i> is the definitive journal for researchers and clinicians in the field of molecular oncology.    </p>
Tags:
oncology
Edit Site Info

What technologies does molecular-cancer.biomedcentral.com use?

These are the technologies used at molecular-cancer.biomedcentral.com. molecular-cancer.biomedcentral.com has a total of 3 technologies installed in 3 different categories.
Tag Managers
Google Tag Manager Google Tag Manager
Caching
Varnish Varnish
Analytics
Zipkin Zipkin

molecular-cancer.biomedcentral.com Traffic Analysis

Molecular-cancer.biomedcentral.com is ranked #4,107 in the world. This website is viewed by an estimated 1.3M visitors daily, generating a total of 2.1M pageviews. This equates to about 37.9M monthly visitors.
Daily Visitors1.3M
Monthly Visits37.9M
Pages per Visit1.65
Visit duration n/a
Bounce Rate n/a
Is this your site?Verify your site's metrics.
Daily Unique Visitors:
1,252,201
Monthly Visits:
37,941,690
Pages per Visit:
1.65
Daily Pageviews:
2,066,132
Avg. visit duration:
n/a
Bounce rate:
n/a
Global Reach:
0.0254%
HypeRank:
4,107
*All traffic values are estimates only.

Visitors by country

Country
Users%
 
China 23.0%
 
United States 20.0%
 
Japan 5.4%
 
India 5.1%
 
United Kingdom 5.0%

Where do visitors go on molecular-cancer.biomedcentral.com?

 
Reach%Pageviews%PerUser
bmcpublichealth.biomedcentral.com
5.68%5.08%1.4
bmcgenomics.biomedcentral.com
5.37%4.37%1.3
biomedcentral.com
4.26%4.59%1.8
bmcbioinformatics.biomedcentral.com
4.25%3.55%1.4
genomebiology.biomedcentral.com
3.62%4.10%1.8
Last update was 2501 days ago
     
This can take up to 60 seconds. Please wait...

*HypeStat.com is not promoting or affiliated with biomedcentral.com in any way. Only publicly available statistics data are displayed.

Moz Data ▼

Domain Authority (DA) is a metric developed by Moz. DA is a score that predicts the ranking potential of a website on search engine result pages (SERPs). Moz calculates Domain Authority on a logarithmic scale from 1 to 100, with higher scores indicating a greater likelihood of ranking well in search results. Moz Domain Authority of molecular-cancer.biomedcentral.com is 91.
Domain Authority:
  91
Page Authority:
  50
MozRank:
  5

  ▼

SEMrush is a complete on line advertising and marketing platform that gives a extensive variety of gear and functions to help companies and entrepreneurs in enhancing their on line visibility and optimizing their virtual advertising and marketing strategies.
SemRushSemRush
Domain:
  molecular-cancer.biomedcentral.com
Rank:
(Rank based on keywords, cost and organic traffic)
  n/a
Organic Keywords:
(Number of keywords in top 20 Google SERP)
  0
Organic Traffic:
(Number of visitors coming from top 20 search results)
  0
Organic Cost:
((How much need to spend if get same number of visitors from Google Adwords)
  $0.00
Full SEMrush Report >>

Revenue report ▼

Google.com would generate approximately $4K per day if the source of income were advertisements, which equates to an estimated monthly revenue of $119.8K and annual gross revenue of approximately $1.5M. Based on these figures, the site's net worth is estimated at around $3.4M.

How much would molecular-cancer.biomedcentral.com make?

Daily Revenue:
$3,993.09
Monthly Revenue:
$119,792.70
Yearly Revenue:
$1,457,477.85
*All earnings values are estimates only.

Daily earning by country

 
CountryPageviewsEarning
 
India 103,307$39.26
 
Malaysia 20,661$5.99
 
Indonesia 20,661$2.27
 
Egypt 0$0.00
 
Taiwan 0$0.00

Loss of money due to Adblock?

Daily Revenue Loss:
$447.79
Monthly Revenue Loss:
$13,433.66
Yearly Revenue Loss:
$163,442.86
Daily Pageviews Blocked:
222,109
Monthly Pageviews Blocked:
6,663,276
Yearly Pageviews Blocked:
81,069,854

Daily revenue loss by country

 
CountryBlockedLost Money
 
India 28,926$10.99
 
Indonesia 11,984$1.32
 
Malaysia 1,653$0.48
 
Egypt 0$0.00
 
Taiwan 0$0.00

How much is molecular-cancer.biomedcentral.com worth?

Website Value:
$3.4M

Ad Experience Report ▼

Summary of the ad experience rating of a website for a specific platform.

Mobile summary

Root domain:
biomedcentral.com
Ad filtering:
(Chrome is not filtering ads on your site.)
Off
Status:
(The status of the site that is reviewed for the Better Ads Standards.)
Not reviewed

Desktop summary

Root domain:
biomedcentral.com
Last Change Time:
(The last time that the site changed status.)
2018-03-29 08:44:28
Ad filtering:
(Chrome is not filtering ads on your site.)
Off
Status:
(The status of the site that is reviewed for the Better Ads Standards.)
Passing

Abusive Experience Report ▼

Summary of the abusive experience rating of a website.
Root domain:
biomedcentral.com
Last Change Time:
(The last time that the site changed status.)
2018-03-29 08:44:28
Enforcement:
(Chrome is not preventing your site from opening new windows or tabs.)
Off
Status:
(The status of the site reviewed for the abusive experiences.)
Not reviewed

Where is molecular-cancer.biomedcentral.com hosted? ▼

Molecular-cancer.biomedcentral.com may be hosted in multiple data centers distributed in different locations around the world. This is probably just one of them.
Server IP:
151.101.196.95
ASN:
AS54113 
ISP:
Fastly 
Server Location:
Los Angeles
California, CA
90009
United States, US
 

Other sites hosted on 151.101.196.95

There are no other sites hosted on this IP

How fast does molecular-cancer.biomedcentral.com load? ▼

The average loading time of molecular-cancer.biomedcentral.com is 1950 ms. The Desktop speed index is 61 and mobile speed index is 99.
Average Load Time:
1950 ms

Page Speed (Google PageSpeed Insights) - Desktop

61
0-49 50-89 90-100 i

Field Data

Over the last 30 days, the field data shows that this page has a speed compared to other pages in the Chrome User Experience Report.We are showing the 90th percentile of FCP and the 95th percentile of FID.

Cumulative Layout Shift (CLS)0 0% of loads for this page have a fast (<0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have an average (0s ~ 0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have a slow (>0s) Cumulative Layout Shift (CLS) 0%
Time To First Byte (TTFB)0 0% of loads for this page have a fast (<0s) Time To First Byte (TTFB) 0% 0% of loads for this page have an average (0s ~ 0s) Time To First Byte (TTFB) 0% 0% of loads for this page have a slow (>0s) Time To First Byte (TTFB) 0%
First Contentful Paint (FCP)0 0% of loads for this page have a fast (<0s) First Contentful Paint (FCP) 0% 0% of loads for this page have an average (0s ~ 0s) First Contentful Paint (FCP) 0% 0% of loads for this page have a slow (>0s) First Contentful Paint (FCP) 0%
First Input Delay (FID)0 0% of loads for this page have a fast (<0ms) First Input Delay (FID) 0% 0% of loads for this page have an average (0ms ~ 0ms) First Input Delay (FID) 0% 0% of loads for this page have a slow (>0ms) First Input Delay (FID) 0%
Interaction To Next Paint (INP)0 0% of loads for this page have a fast (<0ms) Interaction To Next Paint (INP) 0% 0% of loads for this page have an average (0ms ~ 0ms) Interaction To Next Paint (INP) 0% 0% of loads for this page have a slow (>0ms) Interaction To Next Paint (INP) 0%
Largest Contentful Paint (LCP)0 0% of loads for this page have a fast (<0ms) Largest Contentful Paint (LCP) 0% 0% of loads for this page have an average (0ms ~ 0ms) Largest Contentful Paint (LCP) 0% 0% of loads for this page have a slow (>0ms) Largest Contentful Paint (LCP) 0%

Origin Data

All pages served from this origin have an speed compared to other pages in the Chrome User Experience Report. over the last 30 days.To view suggestions tailored to each page, analyze individual page URLs.

Cumulative Layout Shift (CLS)0 0% of loads for this page have a fast (<0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have an average (0s ~ 0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have a slow (>0s) Cumulative Layout Shift (CLS) 0%
Time To First Byte (TTFB)0 0% of loads for this page have a fast (<0s) Time To First Byte (TTFB) 0% 0% of loads for this page have an average (0s ~ 0s) Time To First Byte (TTFB) 0% 0% of loads for this page have a slow (>0s) Time To First Byte (TTFB) 0%
First Contentful Paint (FCP)0 0% of loads for this page have a fast (<0s) First Contentful Paint (FCP) 0% 0% of loads for this page have an average (0s ~ 0s) First Contentful Paint (FCP) 0% 0% of loads for this page have a slow (>0s) First Contentful Paint (FCP) 0%
First Input Delay (FID)0 0% of loads for this page have a fast (<0ms) First Input Delay (FID) 0% 0% of loads for this page have an average 0ms ~ 0ms) First Input Delay (FID) 0% 0% of loads for this page have a slow (>0ms) First Input Delay (FID) 0%
Interaction To Next Paint (INP)0 0% of loads for this page have a fast (<0ms) Interaction To Next Paint (INP) 0% 0% of loads for this page have an average (0ms ~ 0ms) Interaction To Next Paint (INP) 0% 0% of loads for this page have a slow (>0ms) Interaction To Next Paint (INP) 0%
Largest Contentful Paint (LCP)0 0% of loads for this page have a fast (<0ms) Largest Contentful Paint (LCP) 0% 0% of loads for this page have an average (0ms ~ 0ms) Largest Contentful Paint (LCP) 0% 0% of loads for this page have a slow (>0ms) Largest Contentful Paint (LCP) 0%

Lab Data


Page Speed (Google PageSpeed Insights) - Mobile

99
0-49 50-89 90-100 i

Field Data

Over the last 30 days, the field data shows that this page has a speed compared to other pages in the Chrome User Experience Report.We are showing the 90th percentile of FCP and the 95th percentile of FID.

Cumulative Layout Shift (CLS)0 0% of loads for this page have a fast (<0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have an average (0s ~ 0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have a slow (>0s) Cumulative Layout Shift (CLS) 0%
Time To First Byte (TTFB)0 0% of loads for this page have a fast (<0s) Time To First Byte (TTFB) 0% 0% of loads for this page have an average (0s ~ 0s) Time To First Byte (TTFB) 0% 0% of loads for this page have a slow (>0s) Time To First Byte (TTFB) 0%
First Contentful Paint (FCP)0 0% of loads for this page have a fast (<0s) First Contentful Paint (FCP) 0% 0% of loads for this page have an average (0s ~ 0s) First Contentful Paint (FCP) 0% 0% of loads for this page have a slow (>0s) First Contentful Paint (FCP) 0%
First Input Delay (FID)0 0% of loads for this page have a fast (<0ms) First Input Delay (FID) 0% 0% of loads for this page have an average (0ms ~ 0ms) First Input Delay (FID) 0% 0% of loads for this page have a slow (>0ms) First Input Delay (FID) 0%
Interactive To Next Paint (INP)0 0% of loads for this page have a fast (<0s) Interactive To Next Paint (INP) 0% 0% of loads for this page have an average (0s ~ 0s) Interactive To Next Paint (INP) 0% 0% of loads for this page have a slow (>0s) Interactive To Next Paint (INP) 0%
Largest Contentful Paint (LCP)0 0% of loads for this page have a fast (<0s) Largest Contentful Paint (LCP) 0% 0% of loads for this page have an average (0s ~ 0s) Largest Contentful Paint (LCP) 0% 0% of loads for this page have a slow (>0s) Largest Contentful Paint (LCP) 0%

Origin Data

All pages served from this origin have an speed compared to other pages in the Chrome User Experience Report. over the last 30 days.To view suggestions tailored to each page, analyze individual page URLs.

Cumulative Layout Shift (CLS)0 0% of loads for this page have a fast (<0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have an average (0s ~ 0s) Cumulative Layout Shift (CLS) 0% 0% of loads for this page have a slow (>0s) Cumulative Layout Shift (CLS) 0%
Time To First Byte (TTFB)0 0% of loads for this page have a fast (<0s) Time To First Byte (TTFB) 0% 0% of loads for this page have an average (0s ~ 0s) Time To First Byte (TTFB) 0% 0% of loads for this page have a slow (>0s) Time To First Byte (TTFB) 0%
First Contentful Paint (FCP)0 0% of loads for this page have a fast (<0s) First Contentful Paint (FCP) 0% 0% of loads for this page have an average (0s ~ 0s) First Contentful Paint (FCP) 0% 0% of loads for this page have a slow (>0s) First Contentful Paint (FCP) 0%
First Input Delay (FID)0 0% of loads for this page have a fast (<0ms) First Input Delay (FID) 0% 0% of loads for this page have an average 0ms ~ 0ms) First Input Delay (FID) 0% 0% of loads for this page have a slow (>0ms) First Input Delay (FID) 0%
Interactive To Next Paint (INP)0 0% of loads for this page have a fast (<0s) Interactive To Next Paint (INP) 0% 0% of loads for this page have an average (0s ~ 0s) Interactive To Next Paint (INP) 0% 0% of loads for this page have a slow (>0s) Interactive To Next Paint (INP) 0%
Largest Contentful Paint (LCP)0 0% of loads for this page have a fast (<0s)Largest Contentful Paint (LCP) 0% 0% of loads for this page have an average (0s ~ 0s)Largest Contentful Paint (LCP) 0% 0% of loads for this page have a slow (>0s)Largest Contentful Paint (LCP) 0%

Lab Data

Does molecular-cancer.biomedcentral.com use compression? ▼

Website compression is the process of reducing the size of website files, such as HTML, CSS, JavaScript, and image files, to improve website performance and load times. Compressing website files can significantly reduce the amount of data that needs to be transferred from the server to the user's browser, resulting in faster page load times and improved user experience. Files on molecular-cancer.biomedcentral.com are reduced by %.
molecular-cancer.biomedcentral.com does not use compression.
Original size: n/a
Compressed size: n/a
File reduced by: (%)

Google Safe Browsing ▼

Google Safe Browsing is a service provided by Google that helps protect users from visiting websites that may contain malicious or harmful content, such as malware, phishing attempts, or deceptive software.
This site is not currently listed as suspicious

SSL Checker - SSL Certificate Verify ▼

An SSL (Secure Sockets Layer) certificate is a digital certificate that establishes a secure encrypted connection between a web server and a user's web browser. It provides authentication and encryption, ensuring that data transmitted between the server and the browser remains private and protected. molecular-cancer.biomedcentral.com supports HTTPS.
 molecular-cancer.biomedcentral.com supports HTTPS
     
Verifying SSL Support. Please wait...
Common Name: springer2.map.fastly.net
Organization: Fastly, Inc.
Location: San Francisco, California, US
Issuer: GlobalSign CloudSSL CA - SHA256 - G3
Valid from: May 18 10:40:08 2018 GMT
Valid until: Jun 24 17:02:12 2018 GMT
Authority: Is not a CA
Keysize:
Common Name: GlobalSign CloudSSL CA - SHA256 - G3
Organization: GlobalSign nv-sa
Location: BE
Issuer: GlobalSign Root CA
Valid from: Aug 19 00:00:00 2015 GMT
Valid until: Aug 19 00:00:00 2025 GMT
Authority: Is a CA
Keysize: 2048 Bits

Verify HTTP/2 Support ▼

HTTP/2 (Hypertext Transfer Protocol version 2) is a major revision of the HTTP protocol, which is the foundation of data communication on the World Wide Web. It was developed as an improvement over the previous HTTP/1.1 version to enhance web performance and efficiency.
 molecular-cancer.biomedcentral.com supports HTTP/2
     
Verifying HTTP/2.0 Support. Please wait...

Site Categories ▼

Website categories are used to classify websites based on their content or purpose. These categories provide a way to organize and filter websites, allowing users to find relevant information or ensure compliance with specific regulations or policies.
Journals/Free Online Journals
Publications/Journals

Http Header ▼

HTTP headers are extra portions of records despatched among a consumer (which include an internet browser) and a server at some stage in an HTTP request or response. They offer instructions, metadata, or manipulate parameters for the conversation among the consumer and server. 
HTTP/1.1 301 Moved Permanently
Cache-Control: public,max-age=600
Content-Type: text/html
Location: http://molecular-cancer.biomedcentral.com/
Server: Oscar Platform 201802052158-127
X-Vcap-Request-Id: 027be8ce-9b80-4ae1-4413-68f342d91e7a
Content-Length: 182
Accept-Ranges: bytes
Date: Sun, 20 May 2018 06:43:35 GMT
Via: 1.1 varnish
Age: 0
Connection: close
X-Served-By: cache-bur17545-BUR
X-Cache: MISS
X-Cache-Hits: 0
X-Timer: S1526798615.420617,VS0,VE145
Vary: x-forwarded-host, upgrade-insecure-requests
HTTP/1.1 302 Found
Cache-Control: private,no-cache,no-store
Content-Security-Policy: upgrade-insecure-requests;
Content-Type: text/html
Location: https://molecular-cancer.biomedcentral.com/
Server: Oscar Platform 201802052158-127
X-Vcap-Request-Id: b8bf0e14-ca0f-4e6e-60df-d92760c1c630
Content-Length: 158
Accept-Ranges: bytes
Date: Sun, 20 May 2018 06:43:35 GMT
Via: 1.1 varnish
Age: 0
Connection: close
X-Served-By: cache-bur17540-BUR
X-Cache: MISS
X-Cache-Hits: 0
X-Timer: S1526798616.734193,VS0,VE152
Vary: x-forwarded-host, upgrade-insecure-requests
HTTP/1.1 200 OK
Cache-Control: private, must-revalidate
Content-Md5: 3el7DPwm+fZg7DEPbI8Aug==
Content-Type: text/html; charset="UTF-8"
Etag: "dde97b0cfc26f9f660ec310f6c8f00ba"
Expires: 0
Server: Oscar Platform 201802052158-127
Strict-Transport-Security: max-age=31536000;includeSubDomains;preload
X-B3-Spanid: 83cb884e32a8ffd5
X-B3-Traceid: ef388dd8c8cfbaed
X-Content-Type-Options: nosniff
X-Forwarded-Host: molecular-cancer.biomedcentral.com
X-Frame-Options: DENY
X-Sn-Servicetimems: 147
X-Vcap-Request-Id: 17c77e8f-6ec2-456c-6d9a-d190a44294a4
X-Vcap-Request-Id: d4f7d365-2811-4788-6f9b-8e6adb97bd5b
X-Xss-Protection: 1; mode=block
Content-Length: 79918
Accept-Ranges: bytes
Date: Sun, 20 May 2018 06:43:36 GMT
Via: 1.1 varnish
Age: 0
Connection: close
X-Served-By: cache-bur17534-BUR
X-Cache: MISS
X-Cache-Hits: 0
X-Timer: S1526798616.236945,VS0,VE330
Vary: Accept-Encoding,Accept,x-oscar-cache-mode,x-springer-property-json,X-Frame-Options